Feasibility study of fiducial marker localization using microwave radar

Abstract

We explore the potential use of radar technology for fiducial marker tracking for monitoring of respiratory tumor motion during radiotherapy. Historically microwave radar technology has been widely deployed in various military and civil aviation applications to provide detection, position, and tracking of single or multiples objects from far away and even through barriers. Recently,due to many advantages of the microwave technology,it has been successfully demonstrated to detect breast tumor, and to monitor vital signs in real time such as breathing signals or heart rates. We demonstrate a proof -of -concept for radarbased fiducial marker tracking through the synthetic human tissue phantom. Methods: We performed a series of experiments with the vector network analyzer (VNA) and wideband directional horn antenna. We considered the frequency range from 2.0 to 6.0 GHz, with a maximum power of 3 dBm. A horn antenna, transmitting and receiving radar pulses, was connected to the vector network analyzer to probe a gold fiducial marker through a customized synthetic human tissue phantom, consisting of 1-mm thickness of skin, 5-mm fat, and 25-mm muscle layers. A 1.2 × 10-mm gold fiducial marker was exploited as a motion surrogate, which was placed behind the phantom and statically positioned with an increment of 12.7 mm to simulate different marker displacements. The returned signals from the marker were acquired and analyzed to evaluate the localization accuracy as a function of the marker position. Results: The fiducial marker was successfully localized at various measurement positions through a simplified phantom study. The averaged localization accuracy across measurements was 3.5 ± 1.3 mm, with a minimum error of 1.9 mm at the closest measurement location and a maximum error of 4.9 mm at the largest measurement location. Conclusions: We demonstrated that the 2-6 GHz radar can penetrate through the attenuating tissues and localize a fiducial marker. This successful feasibility study establishes a foundation for further investigation of radar technology as a non-ionizing tumor localization device for radiotherapy. K E Y W O R D S development (new technology and techniques), microwave, motion management (intrafraction)

A phantom-based analysis for tracking intra-fraction pancreatic tumor motion by ultrasound imaging during radiation therapy

“…Recently, Han-Oh et al. tested the feasibility of monitoring fiducial markers’ location by using microwave radar ( 20 ). Their results proved this microwave radar technology is a potential non-ionizing tumor tracking device during radiation therapy ( 20 ).…”

Finite Element-Based Personalized Simulation of Duodenal Hydrogel Spacer: Spacer Location Dependent Duodenal Sparing and a Decision Support System for Spacer-Enabled Pancreatic Cancer Radiation Therapy

“…Recent studies have shown that RT together with dose escalation increases the OS at 2 years from 19% to 36%, and at 3 years from 9% to 31% ( 8 , 9 ). Reaching the biologically effective dose (BED 10 ) of 70 Gy can considerably improve LC and overall survival rate ( 4 , 10 – 15 ). However, the major concern with dose escalation is the toxicity of adjacent organs at risk (OARs), namely, stomach, bowel, and primarily duodenum, due to its proximity to the pancreas.…”

Demonstrating the benefits of corrective intraoperative feedback in improving the quality of duodenal hydrogel spacer placement

“…Our group has shown that injection of hydrogel spacer between the head of pancreas (HOP) and duodenum increases the duodenal sparing, and therefore, makes the dose escalation more feasible. [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] However, the success of the spacer placement procedure is highly uncertain. Previous studies on rectal spacer have shown that hydrogel spacer injection is associated with risk of infection, inflammation, and softtissue wall infiltration.…”

“…However, the effectiveness of dose escalation is limited due to the proximity of organs at risk (OAR), mainly the duodenum. Our group has shown that injection of hydrogel spacer between the head of pancreas (HOP) and duodenum increases the duodenal sparing, and therefore, makes the dose escalation more feasible 3–17 …”